Eaton Vance Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Eaton Vance Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	$41.8M	Buy	60,662 +266	+0.4%	+$183K	0.06%	301
2022 Q2	$35.7M	Buy	60,396 +3,143	+5%	+$1.86M	0.05%	337
2022 Q1	$40M	Buy	57,253 +25,907	+83%	+$18.1M	0.05%	357
2021 Q4	$19.8M	Buy	31,346 +96	+0.3%	+$60.6K	0.02%	478
2021 Q3	$18.5M	Buy	31,250 +1,939	+7%	+$1.15M	0.03%	446
2021 Q2	$16.4M	Buy	29,311 +438	+2%	+$245K	0.02%	494
2021 Q1	$13.7M	Buy	28,873 +51	+0.2%	+$24.1K	0.02%	504
2020 Q4	$13.9M	Sell	28,822 -1,041	-3%	-$503K	0.02%	471
2020 Q3	$16.7M	Buy	29,863 +1,835	+7%	+$1.03M	0.03%	391
2020 Q2	$17.5M	Buy	28,028 +2,006	+8%	+$1.25M	0.04%	357
2020 Q1	$12.7M	Buy	26,022 +53	+0.2%	+$25.9K	0.03%	363
2019 Q4	$9.75M	Buy	25,969 +4,003	+18%	+$1.5M	0.02%	459
2019 Q3	$6.09M	Buy	21,966 +12	+0.1%	+$3.33K	0.01%	547
2019 Q2	$6.87M	Sell	21,954 -1,407	-6%	-$440K	0.02%	512
2019 Q1	$9.59M	Sell	23,361 -26	-0.1%	-$10.7K	0.02%	420
2018 Q4	$8.74M	Sell	23,387 -174	-0.7%	-$65K	0.02%	397
2018 Q3	$9.52M	Hold	23,561	–	–	0.02%	419
2018 Q2	$8.13M	Sell	23,561 -94,619	-80%	-$32.6M	0.02%	433
2018 Q1	$40.7M	Buy	118,180 +54,578	+86%	+$18.8M	0.05%	270
2017 Q4	$23.9M	Buy	63,602 +5,332	+9%	+$2M	0.06%	254
2017 Q3	$26.1M	Buy	58,270 +1,500	+3%	+$671K	0.07%	233
2017 Q2	$27.9M	Buy	56,770 +9,743	+21%	+$4.79M	0.07%	222
2017 Q1	$18.2M	Sell	47,027 -21,401	-31%	-$8.29M	0.05%	260
2016 Q4	$25.1M	Buy	68,428 +4,416	+7%	+$1.62M	0.07%	204
2016 Q3	$25.7M	Sell	64,012 -47,538	-43%	-$19.1M	0.07%	199
2016 Q2	$39M	Buy	111,550 +107,300	+2,525%	+$37.5M	0.11%	167
2016 Q1	$1.53M	Sell	4,250 -50	-1%	-$18K	﹤0.01%	603
2015 Q4	$2.33M	Sell	4,300 -655	-13%	-$356K	0.01%	537
2015 Q3	$2.31M	Buy	4,955 +240	+5%	+$112K	0.01%	528
2015 Q2	$2.41M	Buy	4,715 +200	+4%	+$102K	0.01%	506
2015 Q1	$2.04M	Buy	+4,515	New	+$2.04M	0.01%	557